Buy recommendation for $BONEX (+0,23 %) remains unchanged; price target raised from 330 SEK to 360 SEK. This represents an upside of a solid 50% from today’s price.

Rationale: ABG considers the stock’s current valuation to be “very attractive.” The research firm is convinced that Bonesupport will be able to deliver sustained, strong, and profitable growth that exceeds market expectations.

Growth drivers: The main driver of this growth is the product Cerament G is cited as the main driver of this growth, particularly in the U.S. market, where continued high demand and strong market penetration are expected.

Translation and summary by Gemini from the following article: https://efn.se/abg-bonesupports-vardering-mycket-attraktiv